Tyler Levy

机构：Cell Signaling Technology (United States) · ORCID：0000-0003-4634-4063

发表论文 20 篇 · 总被引 1706 次 · h-index 10

代表论文

• Human and mouse single-nucleus transcriptomics reveal TREM2-dependent and TREM2-independent cellular responses in Alzheimer’s disease (2020 · Nature Medicine · 被引 1232)
• Host protein kinases required for SARS-CoV-2 nucleocapsid phosphorylation and viral replication (2022 · Science Signaling · 被引 99)
• Integration of protein phosphorylation, acetylation, and methylation data sets to outline lung cancer signaling networks (2018 · Science Signaling · 被引 73)
• The FDA-approved drug Alectinib compromises SARS-CoV-2 nucleocapsid phosphorylation and inhibits viral infection in vitro (2020 · bioRxiv (Cold Spring Harbor Laboratory) · 被引 63)
• Quantitative Profiling of Post-translational Modifications by Immunoaffinity Enrichment and LC-MS/MS in Cancer Serum without Immunodepletion (2015 · Molecular & Cellular Proteomics · 被引 63)
• A multi-purpose, regenerable, proteome-scale, human phosphoserine resource for phosphoproteomics (2022 · Nature Methods · 被引 53)